PRESS RELEASE published on 10/09/2026 at 14:58, 21 days 6 hours ago Inside Information / Other news releases Medincell resumes trading on Euronext Paris after temporary suspension. The company specializes in long-acting injectable treatments using innovative technologies Innovation Euronext Paris Trading Medincell Long-acting Injectable Treatments
PRESS RELEASE published on 10/09/2026 at 14:58, 21 days 6 hours ago Informations privilégiées / Autres communiqués Reprise de cotation des actions Medincell sur Euronext Paris le 9 octobre 2026 à 14h45. Medincell, société biopharmaceutique innovante, développe des traitements injectables à action prolongée dans divers domaines thérapeutiques Euronext Actions Biopharmaceutique Cotation Medincell
BRIEF published on 10/09/2026 at 14:01, 21 days 7 hours ago Medincell receives FDA approval for WELTRUZA™ FDA Schizophrenia Medincell Olanzapine WELTRUZA™
BRIEF published on 10/09/2026 at 14:01, 21 days 7 hours ago Medincell obtient l'approbation de la FDA pour WELTRUZA™ FDA Schizophrénie Medincell Olanzapine WELTRUZA™
PRESS RELEASE published on 10/09/2026 at 13:56, 21 days 7 hours ago Inside Information / Other news releases Medincell achieves major milestone with U.S. FDA approval of WELTRUZA™ (olanzapine), offering a new treatment option for adults with schizophrenia FDA Approval Schizophrenia Medincell Long-acting Injectable WELTRUZA
PRESS RELEASE published on 10/09/2026 at 13:56, 21 days 7 hours ago Informations privilégiées / Autres communiqués Medincell franchit une étape majeure avec l'approbation de WELTRUZA™ (olanzapine) par la FDA américaine. Lancement de WELTRUZA™ aux États-Unis imminent Schizophrénie Medincell WELTRUZA Approbation FDA Injection Prolongée
BRIEF published on 10/09/2026 at 09:43, 21 days 11 hours ago Medincell Temporarily Suspends Trading on Euronext Paris Euronext Paris Biopharmaceuticals Trading Suspension Medincell BEPO Technology
BRIEF published on 10/09/2026 at 09:43, 21 days 11 hours ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Produits Biopharmaceutiques Medincell Suspension Des Échanges Technologie BEPO
PRESS RELEASE published on 10/09/2026 at 09:38, 21 days 11 hours ago Inside Information / Other news releases Medincell temporarily suspends trading of its shares on Euronext Paris pending a press release, focusing on long-acting injectable treatments and innovative therapeutic candidates Euronext Paris Suspension Therapeutic Candidates Medincell Long-acting Injectable Treatments
PRESS RELEASE published on 10/09/2026 at 09:38, 21 days 11 hours ago Informations privilégiées / Autres communiqués Medincell annonce la suspension temporaire de la cotation de ses actions sur Euronext Paris en attente d'un communiqué. Medincell est une société biopharmaceutique innovante développant des traitements injectables à action prolongée Biopharmaceutique Cotation Medincell Suspension Temporaire Traitements Injectables
Published on 10/30/2026 at 19:00, 2 hours 18 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 5 hours 48 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 12:20, 8 hours 58 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 9 hours 18 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/30/2026 at 18:38, 2 hours 40 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 18:35, 2 hours 42 minutes ago EQS-Adhoc: hep global GmbH expects to conclude refinancing negotiations only in fiscal year 2027
Published on 10/30/2026 at 18:05, 3 hours 13 minutes ago lePERMISLIBRE divise par trois sa perte d’exploitation au premier semestre 2026
Published on 10/30/2026 at 18:00, 3 hours 18 minutes ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 18:00, 3 hours 18 minutes ago Laboratoires Euromedis - Communiqué résultat semestriel 2026
